Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06440187
Status:
COMPLETED
Last Update Posted:
2024-06-03
First Post:
2018-06-06
Brief Title:
Nivolumab Plus Gemcitabine in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma-HN17-11
Sponsor:
Seoul National University Hospital
Organization:
Seoul National University Hospital
Organization Data
Organization:
Seoul National University Hospital
Class:
OTHER
Study ID:
KCSG-HN-17-11
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Seoul National University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Bhumsuk Keam
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Seoul National University Hospital
Old Name:
None
Old Organization:
None